IFNA1 and respiratory syncytial virus infectious disease: The “Chinese pediatric guideline for the diagnosis, treatment, and prevention of respiratory syncytial virus infection” (41) proposes that recombinant human IFN-α inhalation is safe and effective for RSV-related lower respiratory tract infections and recommends its use.